{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:55:59Z","timestamp":1765727759038,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ahj.2011.11.023","type":"journal-article","created":{"date-parts":[[2012,7,9]],"date-time":"2012-07-09T18:03:53Z","timestamp":1341857033000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Bayesian adaptive trial design in acute heart failure syndromes: Moving beyond the mega trial"],"prefix":"10.1016","volume":"164","author":[{"given":"Sean P.","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Lindsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan B.","family":"Storrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Frank","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Hossein","family":"Rahbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Del Junco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald A.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2011.11.023_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2006.02.038","article-title":"The pathophysiology of acute heart failure\u2014is it all about fluid accumulation?","volume":"155","author":"Cotter","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2011.11.023_bb0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejheart.2008.01.007","article-title":"Fluid overload in acute heart failure\u2014re-distribution and other mechanisms beyond fluid accumulation","volume":"10","author":"Cotter","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2011.11.023_bb0015","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1161\/CIR.0b013e3181f9a223","article-title":"Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association","volume":"122","author":"Weintraub","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2011.11.023_bb0020","doi-asserted-by":"crossref","unstructured":"Collins SP, Pang PS, Lindsell CJ, et al. International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes. Eur J Heart Fail;12:1253\u201360.","DOI":"10.1093\/eurjhf\/hfq133"},{"key":"10.1016\/j.ahj.2011.11.023_bb0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2011.11.023_bb0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2011.11.023_bb0035","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.11.023_bb0040","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.11.023_bb0045","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.11.023_bb0050","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials","volume":"298","author":"McMurray","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.11.023_bb0055","first-page":"1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","volume":"287","author":"VMAC Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.11.023_bb0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardfail.2008.12.013","article-title":"The rationale for an acute heart failure syndromes clinical trials network","volume":"15","author":"Collins","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2011.11.023_bb0065","article-title":"The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study","author":"Mebazaa","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2011.11.023_bb0070","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","article-title":"Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study","volume":"373","author":"Teerlink","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2011.11.023_bb0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jacc.2010.03.051","article-title":"National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities","volume":"56","author":"Peacock","year":"2010","journal-title":"Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2011.11.023_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1927","article-title":"Bayesian clinical trials","volume":"5","author":"Berry","year":"2006","journal-title":"Nat Rev Drug Discov"},{"year":"1999","series-title":"Group sequential methods with applications to clinical trials","author":"Jennision","key":"10.1016\/j.ahj.2011.11.023_bb0085"},{"year":"2010","series-title":"Guidance for the use of Bayesian statistics in medical device clinical trials","author":"Campbell","key":"10.1016\/j.ahj.2011.11.023_bb0090"},{"key":"10.1016\/j.ahj.2011.11.023_bb0105","article-title":"Adaptive clinical trials in oncology","author":"Berry","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ahj.2011.11.023_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2125.1982.tb02015.x","article-title":"Patient subsets and variation in therapeutic efficacy","volume":"14","author":"Simon","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2011.11.023_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/clpt.2009.68","article-title":"I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy","volume":"86","author":"Barker","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2011.11.023_bb0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/1740774509104992","article-title":"Bayesian clinical trials at the University of Texas M.D. Anderson Cancer Center","volume":"6","author":"Biswas","year":"2009","journal-title":"Clin Trials"},{"key":"10.1016\/j.ahj.2011.11.023_bb0125","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10549-011-1895-2","article-title":"Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 Trial (CALGB 150007\/150012; ACRIN 6657)","volume":"132","author":"Esserman","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ahj.2011.11.023_bb0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/sim.4780140302","article-title":"S.G E. Adaptive Assignment Versus Balanced Randomization in Clinical-Trials\u2014a Decision-Analysis","volume":"14","author":"Berry","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2011.11.023_bb0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/sim.2247","article-title":"Continuous Bayesian adaptive randomization based on event times with covariates","volume":"25","author":"Cheung","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2011.11.023_bb0140","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.2011.515","article-title":"A proposed model for initial assessment and management of acute heart failure syndromes","volume":"305","author":"Gheorghiade","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2011.11.023_bb0145","series-title":"Vanderbilt University and University of Cincinnati: NHLBI","article-title":"Improving Heart Failure Risk Stratification in the ED: Stratify 1R01HL088459-01; Treatment Endpoints in Acute Decompensated Heart Failure 1K23HL085387-01A2","author":"Storrow","year":"2007"},{"key":"10.1016\/j.ahj.2011.11.023_bb0150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.annemergmed.2007.02.022","article-title":"Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis","volume":"50","author":"Levy","year":"2007","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ahj.2011.11.023_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2011.11.023_bb0160","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N Engl J Med"},{"year":"2005","series-title":"REVIVE II:Multicenter placebo-controlled trial of levosimendan on clinical status in acutely decompensated heart failure (Abstract)","author":"Packer","key":"10.1016\/j.ahj.2011.11.023_bb0165"},{"key":"10.1016\/j.ahj.2011.11.023_bb0170","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2001","journal-title":"J Am Med Assoc"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870312003225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870312003225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:46:40Z","timestamp":1757569600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870312003225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0002870312003225"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2011.11.023","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bayesian adaptive trial design in acute heart failure syndromes: Moving beyond the mega trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2011.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2012.05.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}